GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Sirio Pharma Co Ltd (SZSE:300791) » Definitions » Ending Cash Position

Sirio Pharma Co (SZSE:300791) Ending Cash Position : ¥554 Mil (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Sirio Pharma Co Ending Cash Position?

Sirio Pharma Co's Ending Cash Position for the quarter that ended in Sep. 2024 was ¥554 Mil.

Sirio Pharma Co's quarterly Ending Cash Position increased from Mar. 2024 (¥404 Mil) to Jun. 2024 (¥484 Mil) and increased from Jun. 2024 (¥484 Mil) to Sep. 2024 (¥554 Mil).

Sirio Pharma Co's annual Ending Cash Position increased from Dec. 2021 (¥709 Mil) to Dec. 2022 (¥1,389 Mil) but then declined from Dec. 2022 (¥1,389 Mil) to Dec. 2023 (¥522 Mil).

Sirio Pharma Co Ending Cash Position Historical Data

The historical data trend for Sirio Pharma Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirio Pharma Co Ending Cash Position Chart

Sirio Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 388.47 207.99 708.73 1,389.46 521.94

Sirio Pharma Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 474.80 521.94 403.85 483.57 554.15

Sirio Pharma Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Sirio Pharma Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1389.456+-867.52
=522

Sirio Pharma Co's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=483.566+70.579
=554

Sirio Pharma Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Sirio Pharma Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Sirio Pharma Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Sirio Pharma Co Ltd (SZSE:300791) » Definitions » Ending Cash Position
Comparable Companies
SZSE:002695 SHSE:605337 SZSE:002481 SHSE:605338 SZSE:003000 SHSE:600073 SHSE:605300 SHSE:603711 SHSE:600300 SHSE:600965 XSWX:NESN KHC GIS XPAR:BN SHSE:603288 NSE:NESTLEIND SZSE:300999 SHSE:600887 TSE:2802 LSE:ABF
Traded in Other Exchanges
N/A
Address
No. 83, Taishan Road, Guangdong Province, Shantou, CHN, 515057
Website
http://www.siriopharm.com
Sirio Pharma Co Ltd is engaged in the research and development, production, sales and technical services of nutrition and health food, food production, sales, import and export of goods.
Executives
Chen Qiong Directors, executives
Yao Zhuang Min Directors, executives
Zheng Li Qun Directors, executives
Yang Rui Directors, executives

Sirio Pharma Co Headlines

No Headlines